TMEM99 Inhibitors
TMEM99 inhibitors Brefeldin A and Monensin are known to disrupt intracellular transport routes, including ER-to-Golgi trafficking, which is a critical step in the maturation and function of transmembrane proteins such as TMEM99. Alteration of this transport could result in the mislocalization or degradation of TMEM99. Tunicamycin and Thapsigargin are agents that target the folding and glycosylation processes within the endoplasmic reticulum (ER). Tunicamycin's inhibition of N-linked glycosylation and Thapsigargin's disturbance of ER calcium homeostasis can lead to a stress response that affects the stability and expression of ER-associated proteins, including TMEM99. Cyclopiazonic acid and DTT further influence protein folding within the ER, with DTT disrupting disulfide bond formation, a process that is often crucial for the proper conformation of transmembrane proteins.
Chloroquine and U18666A can alter the endosomal and lysosomal pathways, as well as intracellular cholesterol distribution, respectively. These alterations can affect the degradation and membrane association of transmembrane proteins. GW4869 and Filipin impact the composition and integrity of lipid rafts, which are specialized membrane microdomains that can play a role in the localization and function of proteins like TMEM99. Lastly, Nocodazole and Nystatin have broader effects on intracellular trafficking and membrane integrity. Nocodazole's disruption of microtubule dynamics can impair the intracellular transport mechanisms that are essential for the correct localization of TMEM99. Nystatin, by perturbing membrane integrity, can affect the overall function of transmembrane proteins.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER-to-Golgi transport, which can affect the trafficking of transmembrane proteins like TMEM99. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Alters Golgi apparatus function, which can influence the processing and trafficking of transmembrane proteins. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, which can affect the folding and stability of glycoproteins like TMEM99. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis in the ER, which can affect the function of ER-associated proteins like TMEM99. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Inhibits the SERCA pump, affecting calcium storage in the ER and potentially impacting TMEM99 function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Raises endosomal and lysosomal pH, which can affect the degradation pathway of proteins like TMEM99. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
Induces intracellular cholesterol accumulation, potentially affecting membrane composition and TMEM99 function. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
Inhibits neutral sphingomyelinase, potentially altering lipid raft composition and TMEM99 localization. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $118.00 $148.00 | 26 | |
Binds to cholesterol, possibly affecting cholesterol-rich membrane domains where TMEM99 may localize. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule polymerization, potentially affecting intracellular transport and localization of TMEM99. | ||||||